Results 1 -
10
of
34
for
Mismatch repair cancer syndrome 1
- ... cancer syndrome Mismatch repair deficiency Genetic Testing Registry: Mismatch repair cancer syndrome 1 Mismatch repair cancer syndrome 1 National Organization for ...
- ... DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME; DGLBC MISMATCH REPAIR CANCER SYNDROME 1; MMRCS1 APC REGULATOR OF WNT SIGNALING PATHWAY; APC ...
- Adult Central Nervous System Tumors Treatment (National Cancer Institute)National Cancer Institute ... From the National Institutes of Health ... Adult central nervous system tumor treatment may include surgery, radiosurgery, radiation ...
- ... Moslein G, Mecklin JP, Nielsen M, Moller P. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596- ...
- ... Moslein G, Mecklin JP, Nielsen M, Moller P. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596- ...
- ... Moslein G, Mecklin JP, Nielsen M, Moller P. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596- ...
- ... Moslein G, Mecklin JP, Nielsen M, Moller P. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596- ...
- ... Moslein G, Mecklin JP, Nielsen M, Moller P. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596- ...
- Treatment Option Overview (Childhood Acute Lymphoblastic Leukemia) (National Cancer Institute)Childhood acute lymphoblastic leukemia (ALL) treatment is usually chemotherapy given in phases and determined by risk group. Radiation therapy, targeted ...
- Risk Groups for Childhood Acute Lymphoblastic Leukemia (National Cancer Institute)Childhood acute lymphoblastic leukemia (ALL) treatment is usually chemotherapy given in phases and determined by risk group. Radiation therapy, targeted ...